[Antilipemic agents and postprandial lipidemia].
Shepherd
J
J
Department of Biochemistry, Royal Infirmary, Glasgow, UK.
Simpson
H
H
Williamson
C M
CM
Pringle
S
S
MacLean
J
J
Lorimer
A R
AR
Packard
C J
CJ
D002784:Cholesterol / Q000097:blood*; D002914:Chylomicrons / Q000097:blood; D003324:Coronary Artery Disease / Q000097:blood* / Q000188:drug therapy; D004041:Dietary Fats / Q000378:metabolism*; D004224:Diterpenes; D005260:Female; D011345:Fenofibrate / Q000008:administration & dosage*; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood* / Q000188:drug therapy; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D008657:Metabolic Clearance Rate / Q000187:drug effects; D008875:Middle Aged; D009525:Niacin / Q000008:administration & dosage*; D000084562:Retinyl Esters; D014280:Triglycerides / Q000097:blood*; D014801:Vitamin A / Q000031:analogs & derivatives / Q000097:blood
D002914:Chylomicrons; D004041:Dietary Fats; D004224:Diterpenes; D008074:Lipoproteins; D000084562:Retinyl Esters; D014280:Triglycerides; D014801:Vitamin A; C014794:retinol palmitate; D009525:Niacin; D002784:Cholesterol; D011345:Fenofibrate
Lipidsenker und postprandiale Lipämie.